NCT06473870Not yet recruiting
Understanding Lung Cancer Related Risk Factors and Their Impact
Source: ClinicalTrials.gov · Last updated 25 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
LUCIA aims to develop prediction models for the early diagnosis of lung cancer based on the identification of risk factors and deeper cellular knowledge, by recording real-world data; with risk assessment tools, non-invasive devices and omics analysis. These models will enable new clinical pathways and diagnostic workflow to be implemented to ensure early diagnosis and confirmation, including classification of lung cancer subtype.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 6160 (estimated)
- First submitted
- 16 May 2024
- Start date
- Jul 2024
- Primary completion date
- Dec 2027
- Lead sponsor
- Biobizkaia Health Research Institute
- Diseases
- Lung cancer
- NCT number
- NCT06473870
What you commit to
- Study type: Observational
- Planned participants: 6160
- From Jul 2024 to the primary completion date, Dec 2027
- 5 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or prior history of lung cancer
- History of neoplasia in the previous 5 years except non-melanoma skin cancer
- Moderate-severe comorbidities that prevent completion of a diagnostic study in the event of findings suggestive of lung neoplasia (by means of the investigator's clinical judgment) or surgical intervention (\< 6 months) if not previously confirmed by cytohistology.
Other illness
- Vulnerable subjects: severe psychiatric comorbidity, adults under guardianship or deprived of liberty
Age
- Subjects under 40 years of age
Other
- Unable to be followed-up for at least 2-years or complete the study
- Subjects that do not sign the informed consent
- Pregnant women
Who the study is looking for
- Subjects aged between 40 and 80 years
- Both genders, of which at least 37% must be women to ensure representativeness
- Willingness and ability to comply with scheduled visits, laboratory tests, and other trial procedures
- Written informed consent obtained prior to performing any protocol-related procedures.
- High risk of developing Lung Cancer volunteers will be selected by Lung Cancer risk factors modelling.
- \- Patients diagnosed with indeterminate pulmonary nodules or Lung Cancer from the screening phases.
Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Universitaire de Liège Coordinator of this site? Confirm its status | Liège | Belgium | Unknown status |
| Hospital Universitario Cruces Coordinator of this site? Confirm its status | Barakaldo | Spain | Unknown status |
| Hospital Universitario Virgen Macarena Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
| Aljarafe-Sevilla Norte Health District Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
| Riga East University Hospital Coordinator of this site? Confirm its status | Riga | Latvia | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.